Summary.
A molecular docking study was performed on several structurally diverse A2A AR antagonists, including xanthines, and non-xanthine type antagonists to investigate their binding modes with A2A adenosine receptor (AR), one of the four subtypes of AR, which is currently of great interest as a target for therapeutic intervention, in particular for Parkinson’s disease. The high-affinity binding site was found to be a hydrophobic pocket with the involvement of hydrogen bonding interactions as well as π–π stacking interactions with the ligands. The detailed binding modes for both xanthine and non-xanthine type A2A antagonists were compared and the essential features were extracted and converted to database searchable queries for virtual screening study of novel A2A AR antagonists. Findings from this study are helpful for elucidating the binding pattern of A2A AR antagonists and for the design of novel active ligands.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
PG Baraldi B Cacciari R Romagnoli G Spalluto A Monopoli E Ongini K Varani PA Borea (2002) ArticleTitle7-Substituted 5-amino-2-(2-furyl)pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines as A2A adenosine receptor antagonists: a study on the importance of modifications at the side chain on the activity and solubility J Med Chem 45 115–126 Occurrence Handle11754583 Occurrence Handle10.1021/jm010924c Occurrence Handle1:CAS:528:DC%2BD3MXoslygsbo%3D
C Barbara P Giorgia S Giampiero (2003) ArticleTitleMedicinal chemistry of A2A adenosine receptor antagonists Curr Top Med Chem 3 403–411 Occurrence Handle10.2174/1568026033392183
J Bockaert JP Pin (1999) ArticleTitleMolecular tinkering of G protein-coupled receptors: an evolutionary success EMBO J 18 1723–1729 Occurrence Handle10202136 Occurrence Handle10.1093/emboj/18.7.1723 Occurrence Handle1:CAS:528:DyaK1MXivVylu7o%3D
KC Chou (2004a) ArticleTitleInsights from modelling the 3D structure of the extracellular domain of alpha7 nicotinic acetylcholine receptor Biochem Biophys Res Commun 319 433–438 Occurrence Handle10.1016/j.bbrc.2004.05.016 Occurrence Handle1:CAS:528:DC%2BD2cXkslSjtLg%3D
KC Chou (2004b) ArticleTitleInsights from modelling the tertiary structure of BACE2 J Proteome Res 3 1069–1072 Occurrence Handle10.1021/pr049905s Occurrence Handle1:CAS:528:DC%2BD2cXmsVSlu7k%3D
KC Chou (2004c) ArticleTitleModelling extracellular domains of GABA-A receptors: subtypes 1, 2, 3, and 5 Biochem Biophys Res Commun 316 636–642 Occurrence Handle10.1016/j.bbrc.2004.02.098 Occurrence Handle1:CAS:528:DC%2BD2cXitFKgs7w%3D
KC Chou (2004d) ArticleTitleMolecular therapeutic target for type-2 diabetes J Proteome Res 3 1284–1288 Occurrence Handle10.1021/pr049849v Occurrence Handle1:CAS:528:DC%2BD2cXosVOktbs%3D
KC Chou (2004e) ArticleTitleReview: structural bioinformatics and its impact to biomedical science Curr Med Chem 11 2105–2134 Occurrence Handle1:CAS:528:DC%2BD2cXlslWltbw%3D
KC Chou (2005a) ArticleTitleCoupling interaction between thromboxane A2 receptor and alpha-13 subunit of guanine nucleotide-binding protein J Proteome Res 4 1681–1686 Occurrence Handle10.1021/pr050145a Occurrence Handle1:CAS:528:DC%2BD2MXmsVyitro%3D
KC Chou (2005b) ArticleTitleModeling the tertiary structure of human cathepsin-E Biochem Biophys Res Commun 331 56–60 Occurrence Handle10.1016/j.bbrc.2005.03.123 Occurrence Handle1:CAS:528:DC%2BD2MXjsFChs7k%3D
KC Chou (2006) Structural bioinformatics and its impact to biomedical science and drug discovery Atta-ur-Rahman AB Reitz (Eds) Frontiers in medicinal chemistry NumberInSeries3 Bentham Science Publishers The Netherlands 455–502
KC Chou AG Tomasselli RL Heinrikson (2000) ArticleTitlePrediction of the tertiary structure of a caspase-9/inhibitor complex FEBS Lett 470 249–256 Occurrence Handle10745077 Occurrence Handle10.1016/S0014-5793(00)01333-8 Occurrence Handle1:CAS:528:DC%2BD3cXitVSrurw%3D
KC Chou KD Watenpaugh RL Heinrikson (1999) ArticleTitleA model of the complex between cyclin-dependent kinase 5(Cdk5) and the activation domain of neuronal Cdk5 activator Biochem Biophys Res Commun 259 420–428 Occurrence Handle10362524 Occurrence Handle10.1006/bbrc.1999.0792 Occurrence Handle1:CAS:528:DyaK1MXjs1Smu7o%3D
KC Chou DQ Wei QS Du S Sirois WZ Zhong (2006) ArticleTitleReview: progress in computational approach to drug development against SARS Curr Med Chem 13 3263–3270 Occurrence Handle17168850 Occurrence Handle10.2174/092986706778773077 Occurrence Handle1:CAS:528:DC%2BD28XhtFyrtr%2FL
KC Chou DQ Wei WZ Zhong (2003) ArticleTitleBinding mechanism of coronavirus main proteinase with ligands and its implication to drug design against SARS Biochem Biophys Res Commun 308 148–151 Occurrence Handle12890493 Occurrence Handle10.1016/S0006-291X(03)01342-1 Occurrence Handle1:CAS:528:DC%2BD3sXlvVCktbk%3D
QS Du S Wang DQ Wei S Sirois KC Chou (2005a) ArticleTitleMolecular modelling and chemical modification for finding peptide inhibitor against SARS CoV Mpro Anal Biochem 337 262–270 Occurrence Handle10.1016/j.ab.2004.10.003 Occurrence Handle1:CAS:528:DC%2BD2MXhtVKiu7k%3D
QS Du SQ Wang ZQ Jiang WN Gao YD Li DQ Wei KC Chou (2005b) ArticleTitleApplication of bioinformatics in search for cleavable peptides of SARS-CoV Mpro and chemical modification of octapeptides Med Chem 1 209–213 Occurrence Handle10.2174/1573406053765468 Occurrence Handle1:CAS:528:DC%2BD2MXksVahurc%3D
QS Du SQ Wang DQ Wei Y Zhu H Guo S Sirois KC Chou (2004) ArticleTitlePolyprotein cleavage mechanism of SARS CoV Mpro and chemical modification of octapeptide Peptides 25 1857–1864 Occurrence Handle15501516 Occurrence Handle10.1016/j.peptides.2004.06.018 Occurrence Handle1:CAS:528:DC%2BD2cXovV2gu7k%3D
QS Du H Sun KC Chou (2007a) ArticleTitleInhibitor design for SARS coronavirus main protease based on “distorted key theory” Med Chem 3 1–6 Occurrence Handle10.2174/157340607779317616 Occurrence Handle1:CAS:528:DC%2BD2sXisVyhsrg%3D
Du QS, Wang SQ, Chou KC (2007b) Analogue inhibitors by modifying oseltamivir based on the crystal neuraminidase structure for treating drug-resistant H5N1 virus. Biochem Biophys Res Commun; doi: 10.1016/j.bbrc.2007.08.025
IJ Elenkov GP Chrousos RL Wilder (2000) ArticleTitleNeuroendocrine regulation of IL-2 and TNF-alpha/IL-10 balance, clinical implications Ann NY Acad Sci 917 94–105 Occurrence Handle11268424 Occurrence Handle1:CAS:528:DC%2BD3cXovFynu7Y%3D Occurrence Handle10.1111/j.1749-6632.2000.tb05374.x
I Feokistov I Biaggioni (1998) ArticleTitlePharmalogical characterization of adenosine A2B receptors Biochem Pharmacol 55 627–633 Occurrence Handle10.1016/S0006-2952(97)00512-1
BB Fredholm AP IJzerman KA Jacobson KN Klotz J Linden (2001) ArticleTitleInternational union of pharmacology, XXV. Nomenclature and classification of adenosine receptors Pharmacol Rev 53 527–552 Occurrence Handle11734617 Occurrence Handle1:CAS:528:DC%2BD38XltVOltQ%3D%3D
WN Gao DQ Wei Y Li H Gao WR Xu AX Li KC Chou (2007) ArticleTitleAgaritine and its derivatives are potential inhibitors against HIV proteases Med Chem 3 221–226 Occurrence Handle17504192 Occurrence Handle10.2174/157340607780620644 Occurrence Handle1:CAS:528:DC%2BD2sXkvFChtb0%3D
Gui XL, Li L, Wei DQ, Zhu YS, Chou KC (2007) Cleavage mechanism of the H5N1 hemagglutinin by trypsin and furin. Amino Acids (in press)
SM Hourani K Boon HM Fooks DJ Prentice (2001) ArticleTitleRole of cyclic nucleotides in vasodilations of the rat thoracic aorta induced by adenosine analogues Br J Pharmacol 133 833–840 Occurrence Handle11454656 Occurrence Handle10.1038/sj.bjp.0704140 Occurrence Handle1:CAS:528:DC%2BD3MXls1WmtLY%3D
AA Ivanov II Baskin VA Palyulin L Piccagli PG Baraldi NS Zefirov (2005) ArticleTitleMolecular modeling and molecular dynamics simulation of the human A2B adenosine receptor. The study of the possible binding modes of the A2B receptor antagonists J Med Chem 48 6813–6820 Occurrence Handle16250640 Occurrence Handle10.1021/jm049418o Occurrence Handle1:CAS:528:DC%2BD2MXhtV2jsLnK
AA Ivanov II Baskin VA Palyulin NS Zefirov (2002) ArticleTitleMolecular modeling the human A1 adenosine receptor and study of the mechanisms of its selective ligand binding Dokl Biochem Biophys 386 271–274 Occurrence Handle12469507 Occurrence Handle10.1023/A:1020715812906
AA Ivanov II Baskin VA Palyulin NS Zefirov (2003) ArticleTitleMolecular modeling of the human A2A adenosine receptor Dokl Biochem Biophys 389 94–97 Occurrence Handle12856413 Occurrence Handle10.1023/A:1023632005607 Occurrence Handle1:CAS:528:DC%2BD3sXjsVKlu7k%3D
J Kim J Wess AM van Rhee T Schöneberg KA Jacobson (1995) ArticleTitleSite-directed mutagenesis identifies residues involved into ligand recognition in the human A2A adenosine receptor J Biol Chem 270 13987–13997 Occurrence Handle7775460 Occurrence Handle10.1074/jbc.270.23.13987 Occurrence Handle1:CAS:528:DyaK2MXmt1yqtrs%3D
LJ Knutsen SM Weiss (2001) ArticleTitlekw-6002 (Kyowa Hakko Kogyo) Curr Opin Invest Drugs 2 668–673 Occurrence Handle1:CAS:528:DC%2BD3MXktlyjtL0%3D
L Li DQ Wei JF Wang KC Chou (2007) ArticleTitleComputational studies of the binding mechanism of calmodulin with chrysin Biochem Biophys Res Commun 358 1102–1107 Occurrence Handle17521610 Occurrence Handle10.1016/j.bbrc.2007.05.053 Occurrence Handle1:CAS:528:DC%2BD2sXmtFKqu70%3D
JJ Matasi JP Caldwell J Hao B Neustadt L Arik CJ Foster J Lachowicz DB Tulshian (2005) ArticleTitleThe discovery and synthesis of novel adenosine receptor (A2A) antagonists Bioorg Med Chem Lett 15 1333–1336 Occurrence Handle15713381 Occurrence Handle10.1016/j.bmcl.2005.01.019 Occurrence Handle1:CAS:528:DC%2BD2MXhtlShuro%3D
CE Müller U Geis J Hipp U Schobert W Frobenius M Pawlowski F Suzuki J Sandoval-Ramírez (1997) ArticleTitleSynthesis and structure-activity relationship of 3,7-dimethyl-1-propargylxanthine derivatives, A2A-selective adenosine receptor antagonists J Med Chem 40 4396–4405 Occurrence Handle9435909 Occurrence Handle10.1021/jm970515+
CE Müller J Sandoval-Ramírez U Schobert U Geis W Frobenius K Klotz (1998) ArticleTitleN,8-(Sulfostyryl)xanthines: water-soluble A2A-selective adenosine receptor antagonists Bioorg Med Chem 6 707–719 Occurrence Handle9681137 Occurrence Handle10.1016/S0968-0896(98)00025-X
Y Nonaka J Shimada H Nonaka N Koike N Aoki H Kobayashi H Kase K Yamaguchi F Suzuki (1993) ArticleTitlePhotoisomerization of a potent and selective adenosine A2 antagonist, (E)-1,3-dipropyl-8-(3,4-dimethoxystyryl)-7-methylxanthine J Med Chem 36 3731–3733 Occurrence Handle8246243 Occurrence Handle10.1021/jm00075a031 Occurrence Handle1:CAS:528:DyaK2cXht1Clsb0%3D
E Ongini M Adami C Ferri R Bertorelli (1997) ArticleTitleAdenosine A2A receptors and neuroprotection Ann NY Acad Sci 825 30–48 Occurrence Handle9369973 Occurrence Handle10.1111/j.1749-6632.1997.tb48412.x Occurrence Handle1:CAS:528:DyaK2sXns1Oltrk%3D
PJ Richardson H Kase PG Jenner (1997) ArticleTitleAdenosine A2A receptor antagonists as new agents for the treatment of Parkinson’s disease Trends Pharmacol Sci 18 338–344 Occurrence Handle9345853 Occurrence Handle1:CAS:528:DyaK2sXmsF2ltLo%3D
R Sauer J Maurinsh U Reith F Fülle KN Klotz CE Müller (2000) ArticleTitleWater-soluble phosphate prodrugs of 1-propargyl-8-styrylxanthine derivatives, A2A-selective adenosine receptor antagonists J Med Chem 43 440–448 Occurrence Handle10669571 Occurrence Handle10.1021/jm9911480 Occurrence Handle1:CAS:528:DC%2BD3cXltVyntw%3D%3D
S Sirois DQ Wei QS Du KC Chou (2004) ArticleTitleVirtual screening for SARS-CoV protease based on KZ7088 pharmacophore points J Chem Inf Comput Sci 44 1111–1122 Occurrence Handle15154780 Occurrence Handle10.1021/ci034270n Occurrence Handle1:CAS:528:DC%2BD2cXhs1yitLc%3D
M Stefano S Giampiero AJ Kenneth (2005) ArticleTitleTechniques: recent developments in computer-aided engineering of GPCR ligands using the human adenosine A3 receptor as an example Trends Pharmacol Sci 25 44–51
R Vassalo JJ Lipsky (1998) ArticleTitleTheophylline: recent advances in the understanding of its mode of action and uses in clinical practice Mayo Clin Proc 73 346–354 Occurrence Handle10.4065/73.4.346
K Varani D Rigamonti S Sipione A Camurri PA Borea F Cattabeni MP Abbracchio E Cattaneo (2001) ArticleTitleAberrant amplification of A2A receptor signaling in striatal cells expressing mutant huntingtin FASEB 15 1245–1247 Occurrence Handle1:CAS:528:DC%2BD3MXlvVOmtLg%3D
CB Vu B Peng G Kumaravel G Smits X Jin D Phadke T Engber C Huang J Reilly S Tam D Grant G Hetu L Chen J Zhang RC Petter (2004a) ArticleTitlePiperazine derivatives of [1,2,4]triazolo-[1,5-a][1,3,5] triazine as potent and selective adenosine A2A receptor antagonists J Med Chem 47 4291–4299 Occurrence Handle10.1021/jm0498405 Occurrence Handle1:CAS:528:DC%2BD2cXls1ekt78%3D
CB Vu P Shields B Peng G Kumaravel X Jin D Phadke J Wang T Engber E Ayyub RC Petter (2004b) ArticleTitleTriamino derivatives of triazolotriazine and triazolopyrimidine as adenosine A2a receptor antagonists Bioorg Med Chem Lett 14 4835–4838 Occurrence Handle10.1016/j.bmcl.2004.07.048 Occurrence Handle1:CAS:528:DC%2BD2cXnt12rsb8%3D
JF Wang DQ Wei L Li SY Zheng YX Li KC Chou (2007a) ArticleTitle3D Structure modeling of cytochrome P450 2C19 and its implication for personalized drug design Biochem Biophys Res Commun 355 513–519 Occurrence Handle10.1016/j.bbrc.2007.01.185 Occurrence Handle1:CAS:528:DC%2BD2sXitFOlsbs%3D
JF Wang DQ Wei Y Lin YH Wang HL Du YX Li KC Chou (2007b) ArticleTitleInsights from modeling the 3D structure of NAD(P)H-dependent D-xylose reductase of Pichia stipitis and its binding interactions with NAD and NADP Biochem Biophys Res Commun 359 323–329 Occurrence Handle10.1016/j.bbrc.2007.05.101 Occurrence Handle1:CAS:528:DC%2BD2sXmtlaiu70%3D
SQ Wang QS Du KC Chou (2007c) ArticleTitleStudy of drug resistance of chicken influenza A virus (H5N1) from homology-modeled 3D structures of neuraminidases Biochem Biophys Res Commun 354 634–640 Occurrence Handle10.1016/j.bbrc.2006.12.235 Occurrence Handle1:CAS:528:DC%2BD2sXhtlOgtbc%3D
SQ Wang QS Du K Zhao AX Li DQ Wei KC Chou (2007d) ArticleTitleVirtual screening for finding natural inhibitor against cathepsin-L for SARS therapy Amino Acids 33 129–135 Occurrence Handle10.1007/s00726-006-0403-1 Occurrence Handle1:CAS:528:DC%2BD2sXotVWqsrs%3D
DQ Wei S Sirois QS Du HR Arias KC Chou (2005) ArticleTitleTheoretical studies of Alzheimer’s disease drug candidate [(2,4-dimethoxy) benzylidene]-anabaseine dihydrochloride (GTS-21) and its derivatives Biochem Biophys Res Commun 338 1059–1064 Occurrence Handle16256952 Occurrence Handle10.1016/j.bbrc.2005.10.047 Occurrence Handle1:CAS:528:DC%2BD2MXht1WjurrJ
DQ Wei QS Du H Sun KC Chou (2006a) ArticleTitleInsights from modeling the 3D structure of H5N1 influenza virus neuraminidase and its binding interactions with ligands Biochem Biophys Res Commun 344 1048–1055 Occurrence Handle10.1016/j.bbrc.2006.03.210 Occurrence Handle1:CAS:528:DC%2BD28XktVOqsL4%3D
DQ Wei R Zhang QS Du WN Gao Y Li H Gao SQ Wang X Zhang AX Li S Sirois KC Chou (2006b) ArticleTitleAnti-SARS drug screening by molecular docking Amino Acids 31 73–80 Occurrence Handle10.1007/s00726-006-0361-7 Occurrence Handle1:CAS:528:DC%2BD28XntVSmsL0%3D
H Wei R Zhang C Wang H Zheng KC Chou DQ Wei (2007) ArticleTitleMolecular insights of SAH enzyme catalysis and their implication for inhibitor design J Theor Biol 244 692–702 Occurrence Handle17069857 Occurrence Handle10.1016/j.jtbi.2006.09.011 Occurrence Handle1:CAS:528:DC%2BD2sXhtVKlsLs%3D
J Wei S Wang S Gao X Dai Q Gao (2007) ArticleTitle3D-Pharmacophore models for selective A2A and A2B adenosine receptor antagonists J Chem Inf Model 47 IssueID2 613–625 Occurrence Handle17330954 Occurrence Handle10.1021/ci600410m Occurrence Handle1:CAS:528:DC%2BD2sXisVGls7o%3D
R Zhang DQ Wei QS Du KC Chou (2006) ArticleTitleMolecular modeling studies of peptide drug candidates against SARS Med Chem 2 309–314 Occurrence Handle16948478 Occurrence Handle10.2174/157340606776930736 Occurrence Handle1:CAS:528:DC%2BD28XmtFSlt7s%3D
Author information
Authors and Affiliations
Additional information
Authors’ address: Qingzhi Gao, Chemistry Department, XenoPort Inc., 3410 Central Expressway, Santa Clara, CA 95051, U.S.A.
Rights and permissions
About this article
Cite this article
Ye, Y., Wei, J., Dai, X. et al. Computational studies of the binding modes of A2A adenosine receptor antagonists. Amino Acids 35, 389–396 (2008). https://doi.org/10.1007/s00726-007-0604-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00726-007-0604-2